ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 153 filers reported holding ACLARIS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vivo Capital, LLC | 2,858,569 | $85,243,000 | 25.08% |
Sofinnova Management VIII, L.L.C. | 1,539,480 | $45,907,000 | 24.21% |
EcoR1 Capital, LLC | 673,100 | $20,072,000 | 5.07% |
Cormorant Asset Management, LP | 800,000 | $23,856,000 | 3.46% |
Perceptive Advisors | 1,260,847 | $37,598,000 | 2.14% |
NEXTHERA CAPITAL LP | 111,500 | $3,325,000 | 1.70% |
Foresite Capital Management III, LLC | 140,000 | $4,175,000 | 1.60% |
ACUTA CAPITAL PARTNERS, LLC | 200,000 | $5,964,000 | 1.41% |
Rock Springs Capital Management LP | 675,000 | $20,129,000 | 1.16% |
CAXTON CORP | 13,263 | $395,000 | 1.13% |